Companies /Healthcare

AMGEN Inc

NASDAQ: AMGN Drug Manufacturers - General
$439.26
▼ $8.02 (−1.79%) today
Markets closed · 11:47am ET

AMGN Coverage Page 49

6:06am ET
Investing

Amgen’s (AMGN) Troubled Quarter

Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net income of $1.02 billion, or 90 cents per share, for the quarter…

Douglas A. McIntyre
3:30am ET
Investing

Nasdaq Short Interest For July

Below is the short interest for key Nasdaq stocks for July, The figures compare July 13 with June 15. 2007. Company                                 Short…

Douglas A. McIntyre
6:49am ET
Investing

Pre-Market Analyst Calls (July 23, 2007)

AFL raised to Overweight at Lehman.AMGN raised to Hold at Citigroup.ASBC cut to Underweight at Lehman.BUD raised to Hold at Citigroup.CKR started as Neutral at JPMorgan.EMN raised to Buy at Citigroup.EOG cut…

Douglas A. McIntyre
7:07am ET
Investing

Pre-Market Stock News (July 12, 2007)

(AA) Alcoa trading up 6% after Rio Tinto gave a higher rival bid over Alcoa’s buyout offer for Alcan.(AAON) AAON announced a 3 for 2 stock split.(AL) Alcan gets a rival $38.1…

Douglas A. McIntyre
8:07pm ET
Investing

Nasdaq Short Interest, June 2007

Below are the major short interest positions for stocks traded on Nasdaq for the period ending June 15 compared to comparable numbers for May. Company                      …

Douglas A. McIntyre
6:29am ET
Investing

Earlybird Analyst Calls (June 14, 2007)

ACL started as Buy at Jefferies.AMGN started as Mkt Perform at Rodman & Renshaw.B started as Outperform at CIBC.CBB started as Buy at UBS.CHE started as Buy at Jefferies.CTL raised to Neutral…

Douglas A. McIntyre
10:08pm ET
Health and Healthcare

Amgen Buys Ilypsa, Diversification Via Acquisition

Amgen (AMGN) is paying a hefty sum to diversify its Aranesp and Epogen franchises.  The company is acquiring developmental-stage Ilypsa, a biotech company based in San Francisco that focuses on kidney disease…

Douglas A. McIntyre
6:30pm ET
Health and Healthcare

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology.  Cancer stocks in the last few weeks have been seeing a muted…

Douglas A. McIntyre
6:18am ET
Investing

Earlybird Analyst Calls (May 21, 2007)

AMGN reitr Neutral at Baird.CAT reiterated Neutral at Baird.CFC cut to Mkt Perform at FBR.CSE cut to Mkt Perform at FBR.HOLX raised to Buy at B of A.NILE cut to Sell at…

Douglas A. McIntyre
11:12am ET
Investing

On Barron’s “Under-Dividend” Crowd

Barron’s did something very interesting this weekend: they covered companies that could be paying out much higher dividends.   This is something investors should applaud as too many companies are determining that shareholders…

Douglas A. McIntyre
6:19am ET
Investing

Earlybird Analyst Calls (MAY 15, 2007)

AMGN cut to Neutral at Baird.AOG cut to Hold at Jefferies.BEAS cut to Neutral at Credit Suisse.BHE started as Neutral at Credit Suisse.CLS started as Underperform at Credit Suisse.COGO started as Overweight…

Douglas A. McIntyre
6:59am ET
Investing

Pre-Market Stock News (May 11, 2007)

(AAPL) Apple’s talks about the Beatles are reportedly close to being settled.(ALL) Allstate is going to stop selling homeowners insurance policies in California.(ALU) Alcatel-Lucent earnings came out, forecasts 10% revenue gains; shares…

Douglas A. McIntyre